Diagnostic performance of magnetic resonance imaging for assessing tumor response in patients with HER2-negative breast cancer receiving neoadjuvant chemotherapy is associated with molecular biomarker profile.

Diagnostic performance of magnetic resonance imaging for assessing tumor response in patients with HER2-negative breast cancer receiving neoadjuvant chemotherapy is associated with molecular biomarker profile.

Item

http://www.wikidata.org/entity/Q35928203

Q35928203

about

How to use magnetic resonance imaging following neoadjuvant chemotherapy in locally advanced breast cancer The role of magnetic resonance imaging in assessing residual disease and pathologic complete response in breast cancer patients receiving neoadjuvant chemotherapy: a systematic review The Changing World of Breast Cancer: A Radiologist's Perspective.Bispecific Antibody Conjugated Manganese-Based Magnetic Engineered Iron Oxide for Imaging of HER2/neu- and EGFR-Expressing Tumors Analysis of complete response by MRI following neoadjuvant chemotherapy predicts pathological tumor responses differently for molecular subtypes of breast cancer.New researches and application progress of commonly used optical molecular imaging technology.Impact of factors affecting the residual tumor size diagnosed by MRI following neoadjuvant chemotherapy in comparison to pathology.Clinical application of magnetic resonance imaging in management of breast cancer patients receiving neoadjuvant chemotherapy.Performance of Mid-Treatment Breast Ultrasound and Axillary Ultrasound in Predicting Response to Neoadjuvant Chemotherapy by Breast Cancer Subtype.

P2860

Q26798419-C728FF30-EE28-4B30-A615-01A323348204 Q34566213-1892F8DA-2143-4F55-A7A2-4B4194187508 Q36217490-7D9EE5D5-D700-4E08-8391-5AB4D4F3265C Q36372353-471061F7-00C0-4FB0-BE78-9D9EFCC5FFF1 Q36475463-03513561-4989-4777-9CAF-30BB9EF78838 Q37627064-5C13C417-5CAC-4639-8870-B627570CFED9 Q37734922-3FC479EE-A084-4447-BDAE-19E885B28DF4 Q44491240-345C8346-2468-43EB-9408-AEAE41DD5679 Q55003756-86009203-333C-4586-9028-F83383D454F9

P2860

Diagnostic performance of magnetic resonance imaging for assessing tumor response in patients with HER2-negative breast cancer receiving neoadjuvant chemotherapy is associated with molecular biomarker profile.

Item

http://www.wikidata.org/entity/Q35928203

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Diagnostic performance of magn ...... h molecular biomarker profile.

@ast

Diagnostic performance of magn ...... h molecular biomarker profile.

@en

type

Item

label

Diagnostic performance of magn ...... h molecular biomarker profile.

@ast

Diagnostic performance of magn ...... h molecular biomarker profile.

@en

prefLabel

Diagnostic performance of magn ...... h molecular biomarker profile.

@ast

Diagnostic performance of magn ...... h molecular biomarker profile.

@en

P1476

Diagnostic performance of magn ...... h molecular biomarker profile.

@en

P2093

Aida Kuzucan

http://www.w3.org/2001/XMLSchema#string

David J B Hsiang

http://www.w3.org/2001/XMLSchema#string

Hon J Yu

http://www.w3.org/2001/XMLSchema#string

Jeon-Hor Chen

http://www.w3.org/2001/XMLSchema#string

John A Butler

http://www.w3.org/2001/XMLSchema#string

Karen T Lane

http://www.w3.org/2001/XMLSchema#string

Min-Ying Su

http://www.w3.org/2001/XMLSchema#string

Peter T Fwu

http://www.w3.org/2001/XMLSchema#string

Philip M Carpenter

http://www.w3.org/2001/XMLSchema#string

Rita S Mehta

http://www.w3.org/2001/XMLSchema#string

P2860

Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2.

Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications

Molecular portraits of human breast tumours

Comparison of triple-negative and estrogen receptor-positive/progesterone receptor-positive/HER2-negative breast carcinoma using quantitative fluorine-18 fluorodeoxyglucose/positron emission tomography imaging parameters: a potentially useful method

Triple-negative breast cancer: correlation between MR imaging and pathologic findings.

Neoadjuvant chemotherapy for breast carcinoma: multidisciplinary considerations of benefits and risks.

Ki-67 can be used for further classification of triple negative breast cancer into two subtypes with different response and prognosis.

Prognostic significance of HER-2 status in women with inflammatory breast cancer

Preoperative (neoadjuvant) systemic treatment of breast cancer.

Using MRI to plan breast-conserving surgery following neoadjuvant chemotherapy for early breast cancer.

P304

110-118

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.CLBC.2012.01.009

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2012-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

221973498

http://www.w3.org/2001/XMLSchema#string

P698

22444717

http://www.w3.org/2001/XMLSchema#string

P921

biomarker

chemotherapy

P932

3342312

http://www.w3.org/2001/XMLSchema#string

Diagnostic performance of magnetic resonance imaging for assessing tumor response in patients with HER2-negative breast cancer receiving neoadjuvant chemotherapy is associated with molecular biomarker profile.

about

P2860

P2860

Diagnostic performance of magnetic resonance imaging for assessing tumor response in patients with HER2-negative breast cancer receiving neoadjuvant chemotherapy is associated with molecular biomarker profile.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P5875

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P5875

P698

P921

P932